Pfizer/BioNTech Updated Covid-19 Vaccine Gets Canadian Approval
Express News | Pfizer/BioNTech's COVID-19 vaccine targeting the KP.2 variant has been approved in Canada.
Pfizer Canada And BioNTech Receive Health Canada Approval Of Omicron KP.2 Variant Adapted COVID-19 Vaccine
BioNTech Shares Poised for Further Upside Amid BNT327 Building Data, Morgan Stanley Says
European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Morgan Stanley Upgrades BioNTech to Overweight From Equalweight, Boosts Price Target to $145 From $93
10 Health Care Stocks With Whale Alerts In Today's Session
BioNTech SE (BNTX) Receives a Hold From Morgan Stanley
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Pfizer/BioNTech New COVID Shot Endorsed by EMA Advisory Panel
BioNTech SE's (NASDAQ:BNTX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
BioNTech's Omicron Vaccine Awaits EU Approval
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
This week's hot US stocks | Chinese concept stocks surge! Li Auto Inc and jd.com lead the way; with the Federal Reserve interest rate cut implemented, the financial crediting sector benefits and rises.
usa's used car dealer Carvana has risen for four consecutive days this week, with a cumulative increase of over 20%, also setting a new high for the year, with a total increase of 222.5% this year.
BioNTech Price Target Raised to $150.00/Share From $95.00 by Deutsche Bank
BioNTech Is Maintained at Buy by Deutsche Bank
Watching BioNTech; Traders Circulating Stock Picked By Popular Retail Trading Newsletter
US stocks mining | The Federal Reserve cuts interest rates more than expected! Multiple real estate-related stocks reach new highs for the year; Accelerate the acquisition plan, US private equity giant KKR rises more than 9% in five days
Soft landing expected to ignite! ai optical communication company Coherent rose nearly 4% on the previous trading day, with a cumulative increase of nearly 90% within the year; ai cloud computing service platform servicenow hit another historical high intraday, with a total annual increase of over 26%.
Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $150
Deutsche Bank analyst Emmanuel Papadakis maintains $BioNTech(BNTX.US)$ with a buy rating, and adjusts the target price from $95 to $150.According to TipRanks data, the analyst has a success rate of 56